Search results for: Innovation Policy Prize

Recently published: Are Wider Societal Effects Considered in Healthcare Decision-making?

29 February 2016

…contact Martina Garau at OHE. Related work: Johannesson, M., Jonsson, B., Jonsson, L., Kobelt, G. and Zethraeus, N., 2009. Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?…

OHE Lunchtime Seminar on 19 April 2016: Evidence that challenges decision makers: experiences and examples

29 March 2016

…one hand, by the pharmaceutical industry and by patient groups for being too cautious in its approach to appraising medical innovation, and, on the other hand, by NHS managers and…

New publication: The current and future burden of late-onset dementia in the UK: estimates and interventions

10 May 2016

…an intervention to offset the projected increase in DALY burden of dementia in the UK by 2025 appears low”. Dr Matthew Norton, Head of Policy at Alzheimer’s Research UK, said:…

OHE at ISPOR Italy Chapter – Rome: Are Wider Societal Effects Considered in Healthcare Decision-making?

17 May 2016

…Technology Assessment in Health Care, 31(6), pp.449-456. Johannesson, M., Jonsson, B., Jonsson, L., Kobelt, G. and Zethraeus, N., 2009. Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective? …

What Drives Variations in Relative Effectiveness Across Countries?

31 May 2016

…between populations and healthcare systems. Relative effectiveness is a key topic within health policy. In Europe, this is due to the need for early information to guide reimbursement and funding…

Around the World in HTAs: Canada – Autonomous yet Collaborative

9 April 2025

…provinces and territories. From CCOHTA in the 1990s to today’s CDA-AMC, HTA processes in Canada have evolved to include greater patient involvement in decision-making and to adopt innovations from other…

Navigating the Intersection of Healthcare and Environmental Sustainability: ISPOR Europe round-up on the inclusion of environmental impact in HTA

17 January 2024

…whether there is a risk of green-washing practices. Finally, she stressed that patients need to be at the centre of policy designs around sustainability. Importantly, policies and healthcare solutions should…

Presentation at the NHS Global Health Volunteering Group Meeting: “The Value of International Volunteering and Placements to the NHS”

…economic value for the NHS from international volunteering is mainly derived from diffusion of innovation in management and service delivery. The private value for the volunteers comes from increased productivity…

Opportunities for Utilising ‘Real World Data’ in South Korea

20 October 2017

…local government and public institutions, or research organisations with an academic or public policy purpose. Opportunities for data linkage are limited, and the patient consent models that guide data use…